High-Resolution Crystal Structure of a Lasso Peptide

Authors

  • Dr. Herbert Nar,

    1. Lead Discovery/Structural Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach/Riss (Germany), Fax: (+49) (0)7351 832888
    Search for more papers by this author
  • Angela Schmid,

    1. Lead Discovery/Structural Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach/Riss (Germany), Fax: (+49) (0)7351 832888
    Search for more papers by this author
  • Dr. Carsten Puder,

    1. Lead Discovery/Structural Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach/Riss (Germany), Fax: (+49) (0)7351 832888
    2. Current address: Global Function Launch, Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Straße 173, 55216 Ingelheim am Rhein (Germany)
    Search for more papers by this author
  • Dr. Olivier Potterat

    1. Lead Discovery/Structural Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach/Riss (Germany), Fax: (+49) (0)7351 832888
    2. Current address: University of Basel, Department of Pharmaceutical Biology, Klingelbergstrasse 50, 4056 Basel (Switzerland)
    Search for more papers by this author

Abstract

original image

Have I got noose for you! Lasso peptides are a growing class of bioactive peptides of microbial origin. The first crystal structure of a member of this family, the glucagon receptor antagonist BI-32169, shows that the fold is built predominantly by regular secondary structural elements and a tight network of hydrogen bonds that are partially shielded from solvent by hydrophobic amino acid side chains. This results in an extraordinarily stable structure that is resistant to thermal unfolding or proteolytic digestion, which facilitates its biological function.

Ancillary